Qnerve 75mg/1500mcg Tablet SR
By Qnerve
Rx
10 Tablet SR in a Strip

Composition
Methylcobalamin(75mg) + Pregabalin(1500mcg)

Manufacturer - Tablets India Limited
Tablets (India) Limited, "Jhaver Centre", 72 Marshalls Road, Chennai 600 008.

Expires on or after
February, 2027

liver
Based on the available limited data, it is likely safe to use Qnerve 75mg/1500mcg Tablet SR in patients with liver disease. There is no strong evidence indicating the need for dose adjustment specifically for individuals with liver issues. However, as a general precaution, it is always advisable to consult with your doctor before starting or continuing the use of Qnerve 75mg/1500mcg Tablet SR if you have any liver-related concerns. Your doctor can provide personalized guidance based on your individual health condition.

kidney
Qnerve 75mg/1500mcg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor before use.

alcohol
When taking Qnerve 75mg/1500mcg Tablet SR, be cautious as it can increase drowsiness when combined with alcohol.

driving
While taking Qnerve 75mg/1500mcg Tablet SR, be cautious as it may reduce alertness, impact vision, and cause drowsiness and dizziness which can impair driving ability. Avoid driving if experiencing these effects.

pregnancy
Qnerve 75mg/1500mcg Tablet SR may not be safe to use during pregnancy, based on limited human studies and harmful effects seen in animal studies. Your doctor will assess the benefits and risks before prescribing. It is important to consult your doctor.

breastfeeding
Caution is advised when breastfeeding while using Qnerve 75mg/1500mcg Tablet SR as it may be unsafe and could potentially harm the baby. Limited data indicates the drug could pass into breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹180
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025